The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Eichorn Laura G. since 2022.
This trader's CIK number is 1861067.
At the time of last reporting, Eichorn Laura G. was the Chief Financial Officer of Imago Biosciences, Inc.. (stock ticker symbol IMGO).
Also see all insider trading activities at Imago Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | IMGO | 0 | $0 | 30,006 | $680,338 | 30,006 | $59,613 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-12-27 | IMGO | Option Ex | 3,100 | 2.52 | 7,812 |
| 2022-12-27 | IMGO | Sale | 3,100 | 35.93 | 111,383 |
| 2022-11-02 | IMGO | Option Ex | 553 | 2.52 | 1,393 |
| 2022-11-02 | IMGO | Sale | 553 | 18.00 | 9,954 |
| 2022-08-22 | IMGO | Option Ex | 447 | 2.52 | 1,126 |
| 2022-08-22 | IMGO | Sale | 447 | 18.00 | 8,046 |
| 2022-08-16 | IMGO | Option Ex | 533 | 2.52 | 1,343 |
| 2022-08-17 | IMGO | Option Ex | 373 | 2.52 | 939 |
| 2022-08-16 | IMGO | Sale | 533 | 19.50 | 10,393 |
| 2022-08-17 | IMGO | Sale | 373 | 19.50 | 7,274 |
| 2022-07-20 | IMGO | Option Ex | 1,000 | 2.52 | 2,520 |
| 2022-07-20 | IMGO | Sale | 1,000 | 18.00 | 18,000 |
| 2022-02-22 | IMGO | Option Ex | 8,000 | 2.52 | 20,160 |
| 2022-02-22 | IMGO | Sale | 8,000 | 21.87 | 174,928 |
| 2022-02-11 | IMGO | Sale | 4,000 | 23.61 | 94,456 |
| 2022-02-11 | IMGO | Option Ex | 4,000 | 1.52 | 6,080 |
| 2022-02-09 | IMGO | Option Ex | 4,000 | 1.52 | 6,080 |
| 2022-02-09 | IMGO | Sale | 4,000 | 21.56 | 86,256 |
| 2022-01-12 | IMGO | Option Ex | 8,000 | 1.52 | 12,160 |
| 2022-01-12 | IMGO | Sale | 8,000 | 19.96 | 159,648 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Eichorn Laura G. (Chief Financial Officer of Imago Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.